A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320.

BACKGROUND: A phase 3 Radiation Therapy Oncology Group (RTOG) study subset analysis demonstrated improved overall survival (OS) with the addition of stereotactic radiosurgery (SRS) to whole brain radiation therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with 1 to 3 brain metastases. Be...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sperduto, Paul W., Wang, Meihua, Robins, H. Ian, Schell, Michael C., Werner-Wasik, Maria, Komaki, Ritsuko, Souhami, Luis, Buyyounouski, Mark K., Khuntia, Deepak, Demas, William, Shah, Sunjay A., Nedzi, Lucien A., Perry, Gad, Suh, John H., Mehta, Minesh P.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3740376/
https://ncbi.nlm.nih.gov/pubmed/23391814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.11.042
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires